Showing 2,181 - 2,200 results of 226,405 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.36s Refine Results
  1. 2181
  2. 2182
  3. 2183

    The Notch1 activation decrease MAF cell viability and proliferation. by Hongwei Shao (493627)

    Published 2021
    “…<p><b>A.</b><i>Top</i>: overexpression of N1<sup>IC</sup> in N1<sup>IC</sup>-GFP/MAF detected by immunoblot. increased Hes-1 expression demonstrates that the Notch pathway is activated. β-actin was used as loading control. …”
  4. 2184
  5. 2185
  6. 2186
  7. 2187

    Cooperative populations have a rescue probability comparable to that of non-cooperative ones only when their growth rate is significantly higher. by Yaron Goldberg (10164674)

    Published 2021
    “…As critical population size increases, the ratio increases since the rescue time window decreases. At a high growth rate ratio, the evolutionary rescue matches only when both populations have no chance of rescue. …”
  8. 2188

    Oxidized LDL decrease Klotho expression in cultured tubular cells. by Cristina Sastre (503532)

    Published 2013
    “…Ox-LDL decreases Klotho mRNA expression, as determined by quantitative RT-PCR, in a time (<b>B</b>) and dose-dependent manner (<b>C</b>) in proximal tubular cells (MCT). …”
  9. 2189
  10. 2190
  11. 2191
  12. 2192
  13. 2193

    NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs by Vivien Béziat (204259)

    Published 2010
    “…</p><h3>Conclusions/Significance</h3><p>Together, these findings call for the reclassification of mature human NK cells into distinct subsets and support a new model, in which the NK cell differentiation and functional fate are based on a stepwise decrease of NKG2A and acquisition of KIRs.…”
  14. 2194
  15. 2195
  16. 2196

    GPR35 is expressed in mouse cortical astrocytes and its activation provokes a decrease of FRSK-induced cAMP production. by Rolando Berlinguer-Palmini (491113)

    Published 2013
    “…Inset: zaprinast (1 µM), a different GPR35 agonist, induces a decrease of FRSK-activated cAMP formation. …”
  17. 2197
  18. 2198
  19. 2199
  20. 2200